Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Vascular Closure Devices Market Outlook from (2023 to 2033)

The vascular closure devices market share is exhibiting significant growth and evolution, as indicated by its market values and forecasted trends. In 2023, the market is valued at around US$ 1,468.4 million, reflecting the growing demand for vascular closure devices.

Looking ahead to 2033, the market is projected to expand even further, reaching a substantial US$ 2,466.5 million. This substantial increase over the decade underscores the escalating importance and adoption of vascular closure devices in medical procedures. From 2023 to 2033, the vascular closure devices market size is anticipated to maintain a steady CAGR of 5.30%. This growth rate reflects the industry's resilience and its ability to adapt to changing healthcare needs.

Adoption Analysis for the Vascular Closure Devices

  • The vascular closure devices market is dynamic, with continuous innovations to enhance patient care and reduce post-procedural complications.
  • Cost remains a key factor influencing the adoption of vascular closure devices. Healthcare facilities weigh the financial implications of these devices against potential benefits.
  • Diverse vascular closure device types are available, allowing healthcare providers to choose the suitable option for specific procedures.
  • Extensive research is underway to assess the benefits of vascular closure devices in terms of reduced bleeding, short hospital stays, and quick patient recovery.
  • A critical aspect of adoption is the evaluation of risks associated with these devices, including complications and adverse events.
  • Ongoing clinical trials provide valuable insights into the safety and effectiveness of different vascular closure devices.
  • The FDA approval process is pivotal in ensuring the adoption of safe and effective vascular closure devices.
  • Collaboration between vascular closure device manufacturers and distributors/suppliers plays a crucial role in device availability and adoption.
  • Adequate training for healthcare professionals is essential for successful device adoption during procedures.
  • Post-procedural aftercare is vital to assess the performance of vascular closure devices and monitor patient recovery.
  • The success rate of devices in achieving hemostasis and the failure rate in cases of complications are closely monitored.
  • Physicians and healthcare facilities evaluate vascular closure device alternatives to determine the best approach for each patient.
Attributes Details
Vascular Closure Devices Market Value for 2023 US$ 1,468.4 million
Vascular Closure Devices Market Value for 2033 US$ 2,466.5 million
Vascular Closure Devices Market Forecast CAGR from 2023 to 2033 5.30%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance and Future Growth of the Vascular Closure Devices Market

The vascular closure devices market has experienced noteworthy changes in recent years, primarily influenced by shifting consumer preferences, environmental considerations, and technological advancements. During the historical period spanning from 2018 to 2022, there was a significant rise in consumer awareness and the adoption of alternative meat sources. This period laid a solid foundation for future growth in the vascular closure devices market.

In this section, we explore the historical performance of the vascular closure devices market and offer insights into its future growth potential, providing valuable perspectives on its trajectory.

Historical CAGR 4.20%
Forecast CAGR 5.30%

Short-term Analysis of Vascular Closure Devices Market from 2018 to 2022

In the short term, spanning from 2018 to 2022, the vascular closure devices market experienced a significant growth rate with a forecasted CAGR of 4.20%. This period marked a substantial surge in the demand for these devices, primarily driven by the increasing prevalence of cardiovascular diseases.

Healthcare facilities increasingly recognized the benefits of vascular closure devices in reducing post-procedural complications leading to a high adoption rate. Hospitals and surgical centers sought to optimize patient care and reduce hospitalization times, which further fueled the adoption.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Mid-term Analysis of Vascular Closure Devices Market from 2023 to 2028

Looking ahead to the mid-term analysis, spanning from 2023 to 2028, the vascular closure devices market is projected to maintain a steady growth trajectory with a forecasted CAGR of 5.30%. The market value is expected to reach around US$ 2,466.5 million in 2033.

Healthcare providers are likely to focus on optimizing the utilization of vascular closure devices in the mid-term period aiming to enhance procedural outcomes and patient satisfaction. Continued advancements in technology and increasing clinical evidence supporting the benefits of these devices will play a pivotal role in driving adoption.

Long-term Analysis of Vascular Closure Devices Market from 2028 to 2033

In the long term, extending from 2028 to 2033, the vascular closure devices market is expected to witness sustained growth. With a forecasted CAGR of 5.30%, the market is poised to reach a value of around US$ 2,466.5 million in 2033.

The adoption of vascular closure devices is likely to become widespread across different regions, during a long-term period, driven by a deep understanding of their benefits and increased healthcare infrastructure investment. Long-term trends indicate a shift toward minimizing complications, reducing hospitalization costs, and enhancing overall patient care, positioning these devices as integral tools in interventional procedures.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Vascular Closure Devices Market Trends

  • Minimally invasive procedures are becoming increasingly popular due to their low risk of complications and short recovery times.
  • There is a rise in the popularity of bioabsorbable vascular closure devices. Bioabsorbable vascular closure devices are made from materials that dissolve over time, which eliminates the need for a second procedure to remove the device.
  • Researchers are constantly developing new technologies for vascular closure. These new technologies offer a variety of advantages over traditional methods, such as fast hemostasis, reduced pain, and improved patient outcomes.
  • Vascular closure devices are now being used in a wider range of procedures, including cardiac catheterization, peripheral vascular interventions, and endovascular surgery.
  • Manufacturers of vascular closure devices are increasingly focused on patient safety. They are developing devices that are less likely to cause complications and are easy to use.
  • As vascular closure devices become popular, regulatory agencies are imposing strict requirements on their safety and effectiveness.
  • Manufacturers are expanding their reach into new markets such as the large bore vascular closure device market. Distributors are becoming active in international markets.

Comparative View of Adjacent Vascular Closure Devices Market

This section provides an in-depth examination of three interconnected markets such as the vascular closure devices market, the heart beat irregularity detection device market, and the vascular access systems market. Within this analysis, we break down the unique characteristics of each market, highlighting their individual CAGRs and market values as of 2023. Furthermore, we delve into the pivotal factors that are shaping the growth of these markets.

Vascular Closure Devices Market:

Attributes Vascular Closure Devices Market
CAGR (2023 to 2033) 5.30%
Market Value (2023) US$ 1,468.4 million
Growth Factor The increasing prevalence of cardiovascular diseases is propelling the vascular closure devices market.
Opportunity Expansion of healthcare infrastructure in emerging markets offers significant growth opportunities.
Key Trends Ongoing technological advancements are shaping the future of vascular closure devices.

Heart Beat Irregularity Detection Device Market:

Attributes Heart Beat Irregularity Detection Device Market
CAGR (2023 to 2033) 4.5%
Market Value (2023) US$ 13.4 million
Growth Factor Growing awareness about heart health is driving the demand for heart closure devices.
Opportunity Telemedicine and remote monitoring are creating new avenues for market growth.
Key Trends Miniaturization of devices for great portability and convenience is a key trend.

Vascular Access Systems Market:

Attributes Vascular Access Systems Market
CAGR (2023 to 2033) 6.7%
Market Value (2023) US$ 9.15 billion
Growth Factor The increasing need for vascular access in healthcare procedures is fueling the vascular access systems market.
Opportunity Advancements in catheter technologies are opening doors for improved vascular access solutions.
Key Trends Integration of digital health solutions for real-time monitoring and management is a prominent trend in the market.

Country-wise Insights

In this dedicated section, our analysts turn their focus to the intricate dynamics of the vascular closure devices market on a country-wise scale. Here, we illuminate the prevailing segments within each nation's unique vascular closure device landscape, unveiling the diverse opportunities and trends that exert their influence over the market's future.

We understand that gaining a comprehensive understanding of these primary categories and their distinctive impact is paramount for market players and stakeholders alike. Each country's role in the vascular closure devices industry from 2023 to 2033 is examined, and our analysis is enriched with insights into the market share held by each nation during this period.

Attributes Details
Value Share of the United States Market in 2023 29.60%
Value Share of Germany Market in 2023 6.70%
Value Share of Japan Market in 2023 2.60%
Value Share of Australia Market in 2023 4.30%
Value Share of China Market in 2023 5.90%
Value Share of India Market in 2023 5.70%

The United States Rules over the Global Vascular Closure Devices Market

The United States assumes a commanding position in the vascular closure devices market, holding a substantial market share of 29.60% in 2023. This dominance can be attributed to a series of strategic factors, including the country's relentless pursuit of technological advancements in the healthcare sector.

The United States boasts a thriving ecosystem of research and development, with numerous academic institutions and private enterprises collaborating to drive innovation in vascular closure devices. This commitment to cutting-edge technology ensures that the devices available in the United States market are at the forefront of efficacy and patient safety.

One prominent trend shaping the United States market is the increasing focus on personalized healthcare solutions. Patients and healthcare professionals are increasingly recognizing the benefits of tailored treatment options, and this trend extends to the use of vascular closure devices.

Manufacturers in the United States are responding to this demand by developing devices that can be customized to individual patient needs, ultimately enhancing patient outcomes and reducing complications.

Another key trend driving the market is the emphasis on user-friendly devices. The United States market is witnessing a surge in the adoption of vascular closure devices that are easy to use and require minimal training.

The growing preference for minimally invasive procedures and outpatient care is driving sales of transradial closure devices in the country. As a result, the United States continues to lead in the adoption of state-of-the-art vascular closure devices, ensuring a bright and dynamic future for the market in the coming years.

Manufacturer’s Excellence in Minimally Invasive Interventions Makes Germany a Key Market

Germany's presence in the vascular closure devices market is marked by excellence in minimally invasive interventions, contributing significantly to its market share from 2023 to 2033. One of the standout trends in Germany’s market is the extensive adoption of vascular closure devices in cardiac interventions.

Cardiac interventions are increasingly relying on vascular closure devices to reduce hospitalization times and enhance patient comfort with the medical tourism industry’s growth. This trend aligns with the global shift toward less invasive approaches and positions Germany as a key player in this domain.

Another factor driving Germany's market share is its emphasis on quality and patient outcomes. The country's healthcare system prioritizes delivering high-quality care and optimizing patient recovery. As a result, vascular closure devices that offer reliability and minimize complications find a receptive market in Germany. Patients and healthcare providers alike value devices that contribute to positive post-procedural experiences.

Technological Precision and Aging Population Create an Opportunistic Future for Japan Market

Japan's notable market share in the vascular closure devices market is driven by a blend of technological precision and its aging population. One of the prevailing trends in Japan’s market is its reputation for technological excellence.

Manufacturers in Japan have gained international acclaim for producing advanced and reliable vascular closure devices. This trend is further bolstered by the country's strict regulatory standards, ensuring that devices meet the high quality and safety criteria.

The demographic landscape plays a pivotal role in driving Japan's peripheral vascular devices market growth. With a substantial aging population, the prevalence of cardiovascular diseases is on the rise.

Collaborations between academic institutions and industry players are a unique growth factor. These partnerships drive research and development efforts, resulting in the introduction of innovative vascular closure devices. Japan's commitment to pushing the boundaries of medical technology positions it as a key contributor to the global vascular closure devices market despite its relatively smaller market share.

In the ever-evolving landscape of VCDs, the market size is consistently influenced by dynamic trends such as increased adoption of bioabsorbable devices and a surge in minimally invasive cardiac interventions.

Quality-Focused Healthcare System Propels Australia Vascular Closure Devices Market

Australia's significant market share in the vascular closure devices market from 2023 to 2033 is characterized by a healthcare system that places a premium on quality. One noteworthy trend in Australia’s market is its growing emphasis on quality-focused healthcare.

Patients and healthcare providers alike prioritize high-quality care, which extends to the choice of vascular closure devices. Devices that offer reliability, minimize complications, and enhance patient outcomes are well-received in Australia.

The country's evolving demographic landscape also contributes to market growth. Australia's aging population, combined with lifestyle changes, leads to an increasing prevalence of cardiovascular conditions. This demographic shift drives the demand for vascular closure devices, particularly in cardiac interventions. Australia's healthcare sector is adapting to meet these changing needs, creating a conducive environment for the adoption of these devices.

Government initiatives aimed at enhancing healthcare infrastructure further bolster the adoption of vascular closure devices. Australia's commitment to providing accessible and efficient healthcare services drives investments in advanced medical technologies, including vascular closure devices. This commitment, coupled with the evolving healthcare landscape, positions Australia as a promising market for these devices.

China to Witness High Demand for Vascular Closure Devices through 2033

China's expanding market share in the vascular closure devices market is fueled by a combination of economic growth and a shift toward minimally invasive procedures. One key trend driving China's market is its rapid economic development. As the country's economy grows, so does access to healthcare services. This has resulted in an increased diagnosis and treatment of cardiovascular disorders, driving the demand for vascular closure devices.

China's expanding network of healthcare facilities is another growth driver. The country's investments in healthcare infrastructure are creating opportunities for the adoption of vascular closure devices. With improved access to advanced medical technologies, China is poised to maintain its substantial market share and contribute significantly to the market's growth.

Diverse Patient Population and Modernization Transforms India into a Lucrative Market

India's considerable market share in the vascular closure devices market is influenced by its diverse patient population and ongoing modernization of the healthcare sector. One of the key trends shaping India’s market is its large and diverse patient base. The country's population diversity contributes to a broad spectrum of cardiovascular conditions, driving the demand for vascular closure devices. India's healthcare sector is adapting to address this diversity, creating opportunities for device manufacturers.

Modernization efforts in India's healthcare sector play a pivotal role in market growth. The country is focused on improving patient outcomes, reducing complications, and minimizing recovery times. These objectives align seamlessly with the adoption of vascular closure devices, which offer benefits such as enhanced patient comfort and quicker recovery. Government initiatives aimed at expanding healthcare access further contribute to the growth of these devices in India.

Category-wise Insights

FMI analysts conduct an in-depth exploration of the dynamics within the vascular closure devices industry within this section. This section continues with a specific focus on the predominant segment within each category. These valuable insights illuminate the prevailing preferences and trends that will mold the future of the vascular closure devices (VCD) market.

In a period of significant industry transformation and expansion, comprehending these pivotal categories and their influence is of paramount importance for both market participants and stakeholders.

Overview of Vascular Closure Devices

Active Approximators Dominate the Vascular Closure Devices Market through Innovation

Attributes Details
Top Product Type Active Approximators
Market Share in 2023 79.20%

Active approximators have emerged as the dominant force in the vascular closure devices market, capturing a substantial market share of 79.20% during the period from 2023 to 2033. This impressive dominance is primarily attributed to their innovative design and advanced features.

Active approximators have redefined the landscape by offering precise control over the closure process, reducing complications, and enhancing patient comfort. Their ability to adapt to varying patient anatomies and deliver reliable hemostasis has made them the preferred choice for healthcare professionals and patients alike.

The continued focus of this segment on research and development, coupled with its commitment to improving patient outcomes, is expected to sustain its leadership in the vascular closure devices industry.

Pioneering Cardiac Interventions Drive the Vascular Closure Devices Market Growth

Attributes Details
Top Application Type Cardiac Interventions
Market Share in 2023 44.60%

The segment dedicated to cardiac interventions has made significant strides, holding a notable market share of 44.60% between 2023 and 2033 within the vascular closure devices market. This dominance can be attributed to the increasing prevalence of cardiac disorders worldwide and the growing adoption of minimally invasive procedures.

Cardiac interventions have witnessed a surge in demand due to their effectiveness in diagnosing and treating various cardiovascular conditions. As technological advancements continue to refine these interventions, such as angioplasty and cardiac stenting, the market is expected to maintain its upward trajectory.

The focus on enhancing patient outcomes, reducing hospitalization time, and improving overall patient experience remains pivotal in sustaining the segment's leadership in the vascular closure devices industry.

Companies Shaping the Future Outlook of the Vascular Closure Devices Industry

The vascular closure devices industry, characterized by its dynamic and evolving nature, is replete with players vying for prominence. This competitive landscape unveils a multifaceted scenario that demands constant innovation, strategic maneuvering, and a keen eye for emerging vascular closure device market opportunities.

Key players invest significantly in research and development to stay at the forefront of technological advancements, ensuring they can offer cutting-edge solutions to healthcare providers and patients alike. To maintain their edge, these market leaders continuously explore novel avenues.

Market players focus on expanding their product portfolios, making strategic acquisitions, and entering into collaborations and partnerships with other industry stakeholders. Moreover, ensuring regulatory compliance and adhering to quality standards is of utmost importance to uphold their reputations.

High manufacturing costs, stringent regulatory frameworks, and the need for skilled professionals are some of the primary challenges faced by both established players and newcomers. Additionally, concerns regarding complications and risks associated with vascular closure devices pose obstacles to their widespread adoption.

There are several opportunities for new entrants eyeing the vascular closure devices market. The growing number of hospitals and surgical centers, especially in emerging markets, presents a ripe environment for product penetration. These newcomers can leverage innovative solutions and cost-effective manufacturing processes to carve out their niche in the industry.

Niche markets and specialized vascular closure devices tailored to address specific medical needs represent a thriving sub-sector within the industry. New entrants with a focus on research and development can capitalize on these opportunities by introducing cutting-edge products catering to niche demands.

Recent Developments in the Vascular Closure Devices Industry:

  • ENDOCOR GmbH & Co. KG received a CE Mark for its ENSURE vascular closure device in 2022. This device is designed for use in the femoral artery and is intended to be a minimally invasive alternative to sutures or staples.
  • Transluminal Technologies LLC received FDA approval for its TRACSEAL vascular closure device in 2022. This device is designed to be used in the radial artery and is intended to be a minimally invasive alternative to sutures or staples.
  • Morris Innovative Inc. received FDA approval for its VASCOSEAL PRO vascular closure device in 2022. This device is designed to be used in the femoral artery and is intended to be a minimally invasive alternative to sutures or staples.
  • Teleflex Incorporated launched the Angio-Seal EZ vascular closure device in 2022. This device can be more easily used and effective than previous generations of Angio-Seal devices.
  • Cook Medical launched the ProGlide Vascular Closure Device in 2023. This device is also more effective than previous generations of ProGlide devices.

Key Companies Operating in the Vascular Closure Devices Market

  • Abbott
  • BIOTRONIK
  • Cardinal Health
  • Cardiva Medical, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Tricol Medical
  • Z-Medica, LLC
  • KOAG LLC

Key Segments

By Product:

  • Passive Approximators
    • Collagen Plugs
    • Sealant or Gel-based Devices
    • Compression-assist Devices
  • Active Approximators
    • Suture-based Devices
    • Clip-based Devices
    • External Haemostatic Devices

By Application:

  • Cardiac Interventions
  • Cerebrovascular Interventions
  • Peripheral Vascular Interventions
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

Frequently Asked Questions

What is the Growth Potential of the Vascular Closure Devices Market?

The growth potential of the market is a CAGR of 5.30% between 2023 and 2033.

What is the Vascular Closure Devices Market Growth Outlook by 2033?

The vascular closure devices market is anticipated to surpass US$ 2,466.5 million by 2033.

What is the Market Share of Vascular Closure Devices in 2023?

The vascular closure devices market is estimated to be worth US$ 1,468.4 million in 2023.

What is a Vascular Closure Device Used for?

Vascular closure devices stop bleeding and close the femoral artery or other access sites.

Is Angioseal a Closure Device?

Yes, Angioseal is a known vascular closure device.

What is Angioseal's Minimum Vessel Size?

Angioseal is generally suitable for vessels of 5 to 6 French (F) or larger.

Table of Content

1. Executive Summary

        1.1. Global Market Outlook

        1.2. Demand-side Trends

        1.3. Supply-side Trends

        1.4. Technology Roadmap Analysis

        1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Passive Approximators

            5.3.1.1. Collagen Plugs

            5.3.1.2. Sealant or Gel-based Devices

            5.3.1.3. Compression-assist Devices

        5.3.2. Active Approximators

            5.3.2.1. Suture-based Devices

            5.3.2.2. Clip-based Devices

        5.3.3. External Haemostatic Devices

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Cardiac Interventions

        6.3.2. Cerebrovascular Interventions

        6.3.3. Peripheral Vascular Interventions

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Cardiac Catheterization Laboratories

    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Application

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Application

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Application

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Application

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Application

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Application

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Application

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product

            16.22.2.2. By Application

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product

            16.23.2.2. By Application

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Abbott

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. BIOTRONIK

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Cardinal Health

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Cardiva Medical, Inc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Medtronic plc

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Merit Medical Systems, Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Teleflex Incorporated

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Terumo Medical Corporation

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Tricol Medical

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Z-Medica, LLC

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. KOAG LLC

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Heart Closure Devices Market

Published : December 2022

Healthcare

Transradial Closure Devices Market

Published : July 2022

Explore Healthcare Insights

View Reports

Vascular Closure Devices Market